Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Medicine Research Profiles
Home
Profiles
Departments, Divisions and Centers
Research output
Deranged energy substrate metabolism in the failing heart
Qi Tian
, Philip M. Barger
Division of Cardiology
Research output
:
Contribution to journal
›
Review article
›
peer-review
12
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Deranged energy substrate metabolism in the failing heart'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Heart Failure
100%
Adenosine Triphosphate
100%
Fatty Acid Oxidation
100%
Peroxisome Proliferator-activated Receptor
100%
Failing Heart
100%
Energy Substrate Metabolism
100%
Transcription Factor
50%
Gene Expression
50%
Energy Metabolism
50%
Family Members
50%
Dysregulation
50%
Cardiac Disease
50%
Long-term Consequences
50%
Heart Disease
50%
Cardiac Energy Metabolism
50%
Pharmaceutical Intervention
50%
Multiple Levels
50%
Cardiac Performance
50%
Adjunctive Therapy
50%
Oxygen Demand
50%
Endogenous Lipids
50%
Synthetic Small Molecules
50%
Biochemistry, Genetics and Molecular Biology
Metabolic Pathway
100%
Peroxisome Proliferator-Activated Receptor
100%
Adenosine Triphosphate
66%
Beta Oxidation
66%
Energy Metabolism
66%
Gene Expression
33%
Lipid
33%
Transcription Factors
33%
Small Molecule
33%
Oxygen Consumption
33%
Heart Performance
33%
Immunology and Microbiology
Energy Metabolism
100%
Peroxisome
100%
Fatty Acid Oxidation
100%
Gene Expression
50%
Oxygen Consumption
50%
Transcription Factors
50%
Heart Performance
50%
Neuroscience
Metabolic Pathway
100%
Peroxisome Proliferator-Activated Receptor
100%
Adenosine Triphosphate
66%
Fatty Acids
66%
Energy Metabolism
66%
Gene Expression
33%
Transcription Factors
33%
Adjuvant Therapy
33%
Nursing and Health Professions
Peroxisome Proliferator Activated Receptor
100%
Adenosine Triphosphate
66%
Heart Disease
66%
Congestive Heart Failure
66%
Fatty Acid
66%
Adjuvant Therapy
33%
Transcription Factors
33%
Cardiac Energy Metabolism
33%
Oxygen Consumption
33%
Pharmacology, Toxicology and Pharmaceutical Science
Peroxisome Proliferator Activated Receptor
100%
Adenosine Triphosphate
66%
Congestive Heart Failure
66%
Fatty Acid
66%
Heart Disease
66%
Transcription Factors
33%